SR One Capital Management, LP
Redwood City CA · SEC CIK 0001910264
$9.15亿2026Q1 申报市值
14持仓数
96.5%前十大占比 · 第一大 29.4%
1 / 0新建仓 / 清仓
26Q126Q2
前十大持仓 占组合比例
2026Q1 买入最多 按季末市值估算
MANE 新建仓+$1.52亿
2026Q1 卖出最多 按季末市值估算
本季没有卖出
2026Q1 持仓明细 点表头排序
导出 CSV 🔒| 代码 | 名称 | 市值 ▲ | 占比 | 股数 | 变动股数 | 变动 | 估算买卖额 | 操作 |
|---|---|---|---|---|---|---|---|---|
| RARE | Ultragenyx Pharmaceutical Inc. | $288.59万 | 0.32% | 137,753 | 0 | 0.0% | — | 不变 |
| — | enGene Holdings Inc. | $509.22万 | 0.56% | 747,750 | 0 | 0.0% | — | 不变 |
| NKTX | Nkarta, Inc. | $703.33万 | 0.77% | 3,333,333 | 0 | 0.0% | — | 不变 |
| OCS | Oculis Holding AG | $1,704.48万 | 1.86% | 641,022 | 0 | 0.0% | — | 不变 |
| ORKA | Oruka Therapeutics, Inc | $2,110.77万 | 2.31% | 430,330 | 0 | 0.0% | — | 不变 |
| SPRY | ARS Pharmaceuticals, Inc. | $3,222.36万 | 3.52% | 4,012,903 | 0 | 0.0% | — | 不变 |
| MLYS | Mineralys Therapeutics Inc. | $4,236.78万 | 4.63% | 1,563,966 | 0 | 0.0% | — | 不变 |
| ALMS | Alumis Inc. | $4,317.65万 | 4.72% | 1,959,896 | 0 | 0.0% | — | 不变 |
| ORIC | ORIC Pharmaceuticals, Inc. | $5,847.69万 | 6.39% | 4,514,929 | 0 | 0.0% | — | 不变 |
| DSGN | Design Therapeutics, Inc. | $6,944.17万 | 7.59% | 6,526,476 | 0 | 0.0% | — | 不变 |
| CRSP | CRISPR Therapeutics AG | $9,698.40万 | 10.59% | 2,038,763 | 0 | 0.0% | — | 不变 |
| ZBIO | Zenas BioPharma, Inc | $9,849.00万 | 10.76% | 5,037,854 | 0 | 0.0% | — | 不变 |
| MANE | Veradermics, Inc. | $1.52亿 | 16.57% | 2,401,868 | 2,401,868 | — | $1.52亿 | 新建仓 |
| — | Arcellx, Inc. | $2.69亿 | 29.43% | 2,346,630 | 0 | 0.0% | — | 不变 |